Table 3. Women with THPO and Gonorrhea Compared to Those with THPO and No Gonorrhea.
Tubo-ovarian abscess, Hydrosalpinx, Pyosalpinx, and Oophoritis (THPO); Emergency Department (ED); Emergency Severity Index (ESI); White Blood Cells (WBC); High Power Field (HPF)
| +THPO and +gonorrhea (N=5) | +THPO and -gonorrhea (N=43) | P-value | |
| Age (years) | 25.2 (2.4); 5 | 33.1 (8.5); 43 | <0.001 |
| Black/African American race, % | 100% (5/5) | 86.1% (37/43) | .37 |
| Arrived to ED by EMS/police, % | 40.0% (2/5) | 11.6% (5/43) | .09 |
| ESI (0-5) | 3 (0); 5 | 3.0 (.2); 42 | .16 |
| Vaginal wet prep WBCs >10/HPF (vs ≤10) | 60.0% (3/5) | 36.8% (14/38) | .32 |
| Vaginal wet prep clue cells, % present | 40.0% (2/5) | 38.2% (13/34) | .94 |
| Vaginal wet prep yeast cells, % present | 0% (0/4) | 3.1% (1/32) | .72 |
| Vaginal wet prep trichomonas, % present | 80.0% (4/5) | 12.5% (4/32) | <0.001 |
| +Chlamydia | 40.0% (2/5) | 4.7% (2/43) | .007 |
| +Trichomonas | 100% (4/4) | 33.3% (5/15) | .02 |
| Urine protein (0-3+) | .8 (.8); 5 | .7 (.9); 40 | .72 |
| Urine WBCs ≥10 cells/HPF (vs <10) | 80.0% (4/5) | 41.9% (13/31) | .17 |
| Urine leukocyte esterase (0-3+) | 1.8 (1.0); 4 | .7 (1.0); 39 | .11 |
| Diagnosed with sepsis, % yes | 0% (0/5) | 2.3% (1/43) | .73 |
| Diagnosed with pelvic inflammatory disease, % yes | 0% (0/5) | 11.6% (5/43) | .42 |